Cite

HARVARD Citation

    Lonze, B. et al. (2022). A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation*. Critical care medicine. 50 (9), pp. 1348-1359. [Online]. 
  
Back to record